Language
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - Bloomberg

News

HomeHome / News / Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - Bloomberg
search
RECENT NEWS

Jun 21, 2023

Odyssey Marine Exploration Announces Partnership with Ocean Minerals LLC for a New Cook Islands Exploration Project

Aug 01, 2023

Analysis of the impact of DGAT1 p.M435L and p.K232A variants on pre

Sep 06, 2023

Could ultra

Oct 10, 2023

Sunrise Group among the world's top ten chemical distributors

Oct 14, 2023

Orally Disintegrating Tablet Excipient Market Research Report 2023

SEND YOUR INQUIRY
SUBMIT

Oct 14, 2024

Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - Bloomberg

The H. Lundbeck headquarters in Valby, Denmark. H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc. in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The

The H. Lundbeck headquarters in Valby, Denmark.

H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc. in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases.

The Danish pharmaceutical company is offering shareholders in the US company Longboard $60 per share in cash, in a transaction that has been unanimously approved by the boards of both companies, according to a statementBloomberg Terminal.